Skip to content

“Set it and forget it”: women’s perceptions and opinions of long-acting topical vaginal gels.

Author(s): Jacob J. van den Berg; Rochelle K. Rosen; Dana E. Bregman; Lara A. Thompson; Kathleen M. Jensen; Patrick F. Kiser; David F. Katz; Karen Buckheit; Robert W. Buckheit; Kathleen M. Morrow

Publication: 2014. "AIDS Behav" 18, 5 (May): 862-70.

Identifier(s): PubMed ID: 24248674; PMCID: PMC4018755; ISSN: 1573-3254; Citation Key: 7414

DOI: https://doi.org/10.1007/s10461-013-0652-4

Publication type: Journal Article

Access: Google Scholar | Tagged | XML

Abstract:

Women’s initial understandings and anticipated acceptability of long-acting vaginal gels as potential anti-HIV microbicides was investigated by exploring the perceptibility variables associated with prototype formulations. Four focus groups with 29 women, aged 18-45, were conducted to consider gel prototypes with varied physicochemical and rheological properties. Participants responded favorably to the concept of long-acting vaginal gels as microbicides. Distinctions in understandings and stated needs regarding product dosing, characteristics, and effectiveness offer valuable insights into product design. Long-acting vaginal gels capable of protecting against HIV/STIs will be a viable option among potential users, with dosing frequency being an important factor in willingness to use.